Frontiers in Hematology

Study Protocol

Published on 06 Dec 2024

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

in Blood Cancer

Theo Leitner
Evgenii Shumilov
Christina Schwitlick
Raphael Koch
Franziska Hamm
Marion Högner
Florian Bassermann
Katja Weisel
Hermann Einsele
Martin Kortüm

Frontiers in Hematology

doi 10.3389/frhem.2024.1436845

648 views

Original Research

Published on 05 Dec 2024

Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study

in Blood Cancer

Manuel Neves
Rita Gerivaz
Graça Esteves
Rui Bergantim
Gisela Ferreira
Henrique Coelho
Celina Afonso
Delfim Duarte
Anabela Neves
Helena Matos Silva

Frontiers in Hematology

doi 10.3389/frhem.2024.1480120

389 views

Review

Published on 03 Dec 2024

Delineation of erythropoietic intermediates by flow cytometry

in Red Cells, Iron and Erythropoiesis

Kathleen E. McGrath

Frontiers in Hematology

doi 10.3389/frhem.2024.1496916

381 views

Original Research

Published on 02 Dec 2024

Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation

in Red Cells, Iron and Erythropoiesis

Stefan Schreier
Prapaphan Budchart
Suparerk Borwornpinyo
Panuwat Lertsithichai
Wannapong Triampo

Frontiers in Hematology

doi 10.3389/frhem.2024.1472609

237 views

Original Research

Published on 26 Nov 2024

Exploring the regenerative capacity of the spleen following irradiation

in Hematopoiesis and Stem Cells

Christie T. M. Short
Helen C. O’Neill
Jonathan K. H. Tan

Frontiers in Hematology

doi 10.3389/frhem.2024.1396672

273 views

Original Research

Published on 22 Nov 2024

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia

in Blood Cancer

Somedeb Ball
Najla H. Al Ali
Akriti G. Jain
Luis E. Aguirre
Seongseok Yun
Onyee Chan
Zhuoer Xie
David A. Sallman
Jeffrey Lancet
Eric Padron

Frontiers in Hematology

doi 10.3389/frhem.2024.1492680

265 views

Case Report

Published on 15 Nov 2024

Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report

in Hematopoiesis and Stem Cells

Nicola Maciocia
Dean Spencer
Paul Maciocia
Anna Childerhouse
Maeve O’Reilly
Elspeth Payne
Claire Roddie

Frontiers in Hematology

doi 10.3389/frhem.2024.1435584

406 views

Case Report

Published on 13 Nov 2024

Case report: VEXAS syndrome and literature review

in Blood Cancer

Can Jones
Stanislav Ivanov
Pablo Ferraro
Souhad Younes
Hugo Fernandez

Frontiers in Hematology

doi 10.3389/frhem.2024.1480436

290 views

Mini Review

Accepted on 05 Nov 2024

Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults

in Blood Cancer

Linda Resar
Tania Jain

Frontiers in Hematology

doi 10.3389/frhem.2024.1483322

Review

Published on 29 Oct 2024

Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring

in Blood Cancer

Binsah George
Kok Hoe Chan
Adan Rios

Frontiers in Hematology

doi 10.3389/frhem.2024.1463410

1,190 views

Editorial

Published on 18 Oct 2024

Editorial: Editors’ showcase: red cells, iron and erythropoiesis

in Red Cells, Iron and Erythropoiesis

Anna Rita Migliaccio

Frontiers in Hematology

doi 10.3389/frhem.2024.1457513

254 views

Perspective

Published on 18 Oct 2024

The CHIP-clinic as the catalyst of preventive medicine

in Blood Cancer

Hans Carl Hasselbalch
Vibe Skov
Lasse Kjaer
Trine Alma Knudsen
Christina Schjellerup Eickhardt-Dalbøge
Christina Ellervik
Sabrina Cordua
Anders Lindholm Sørensen
Sarah Friis Christensen
Marie Hvelplund Kristiansen

Frontiers in Hematology

doi 10.3389/frhem.2024.1459154

648 views

Review

Published on 07 Oct 2024

Clonal evolution: a landmark of MPN evolution

in Blood Cancer

Nabih Maslah
Stephane Giraudier
Bruno Cassinat
Jean-Jacques Kiladjian

Frontiers in Hematology

doi 10.3389/frhem.2024.1473920

790 views

Review

Published on 27 Sep 2024

Recent advancements in gene therapy for sickle cell disease and β-thalassemia

in Gene Therapy, Cell Therapy and Hematology

Lushen Li
Pankaj K. Mandal

Frontiers in Hematology

doi 10.3389/frhem.2024.1468952

3,087 views

Review

Published on 25 Sep 2024

Dissecting dormancy and quiescence in hematopoietic stem cells

in Hematopoiesis and Stem Cells

Liliia Ibneeva
Tatyana Grinenko

Frontiers in Hematology

doi 10.3389/frhem.2024.1401713

749 views

Original Research

Published on 11 Sep 2024

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

in Blood Cancer

Amalia Domingo-González
Rafael Alonso Fernández
Ana Jiménez
Teresa De Soto Álvarez
Ana Lerma-Verdejo
Virginia Pradillo
Gonzalo Benzo Callejo
Jose Sánchez-Pina
Elena Landete
Alberto Velasco-Valdazo

Frontiers in Hematology

doi 10.3389/frhem.2024.1438233

528 views

Navigation group

Articles

Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study

Delineation of erythropoietic intermediates by flow cytometry

Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation

Exploring the regenerative capacity of the spleen following irradiation

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia

Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report

Case report: VEXAS syndrome and literature review

Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults

Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring

Editorial: Editors’ showcase: red cells, iron and erythropoiesis

The CHIP-clinic as the catalyst of preventive medicine

Clonal evolution: a landmark of MPN evolution

Recent advancements in gene therapy for sickle cell disease and β-thalassemia

Dissecting dormancy and quiescence in hematopoietic stem cells

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation